Linagliptin - Boehringer Ingelheim/Eli Lilly and Company
At a glance
- Drug Originator Boehringer Ingelheim
- Drug Licenced by Eli Lilly and Company
- Drug Class Alkynes; Amines; Antihyperglycaemics; Ketones; Piperidines; Purines; Quinazolines; Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
- USA Patent Applicants BOEHRINGER INGELHEIM
- USA Patents 32
- NDAs 1
- International Patents 462
- Patent Applications 2,460
Table of Contents
Disclaimer